Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetrapeptide repeat homeobox protein 2 (TPRX2) is a homeobox-containing, presumed transcription factor belonging to the tetra-peptide repeat homeobox (TPRX) family. It is currently considered a pseudogene in the human genome and is not recognized as a validated protein-coding gene in humans. TPRX2 is not described as having a recognized direct biological function, is not a therapeutic target, and is not involved in known drug interactions or disease mechanisms. The confusion with the unrelated protein TPX2 ("Targeting protein for Xklp2," a microtubule-associated protein and mitotic regulator[1][2][3][4][5]) is common due to similar abbreviations, but they are distinct gene products. As currently annotated, "tetrapeptide repeat homeobox 2" does not have a well-defined role in human physiology or pathology and should not be considered a drug target. Notes: There is significant confusion with "TPX2" (Targeting protein for Xklp2), a completely unrelated protein that is an important mitotic spindle assembly factor, microtubule-associated protein, and cancer biomarker[1][2][3][4][5]. None of the search results provide evidence that TPRX2 (tetrapeptide repeat homeobox 2) is a receptor, enzyme, or viable therapeutic target, nor do they offer details on molecular function, drug interaction, or disease involvement. Most hits refer to TPX2 (not TPRX2), suggesting the original query target is either misspecified or not a well-characterized molecule in biomedical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetrapeptide repeat homeobox protein 2 (TPRX2).